CADL - Candel Therapeutics Company Long-Term Liabilities

Public company logo of candeltx.com (CADL)

Candel Therapeutics (CADL) is developing methods to combat brain and prostate tumors, relying on payments from government funds and insurers. The company is currently spending its raised capital, as it has no commercial products. This daily price chart on GURU.Markets captured the 0.05 metric. Looking ahead, the business plans to expand its oncology presence by scaling viral therapy and successfully completing medical trials.

Candel Therapeutics (CADL) Company Long-Term Debt: for the period 07/04/2022 - 10/29/2026

Candel Therapeutics, Inc. (CADL) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price Candel Therapeutics Inc.|CADL - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Candel Therapeutics|CADL - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share Candel Therapeutics|CADL - Company Book Value|Market Value to Book Value candeltx.com|CADL - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Candel Therapeutics|CADL - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Candel Therapeutics Inc.|CADL - Company Total Debt|Debts to Book Capitalization Candel Therapeutics|CADL - Company Long-Term Debt|Company Short-Term Loans and Borrowings Candel Therapeutics|Immediate Liquidity candeltx.com
- earnings and market multiples details:
CADL - Net Profit
Fundamental company valuation:CADL (Candel Therapeutics)
Brand item of Candel

This indicator reflects the total volume of long-term liabilities, determining the actual financial burden on the business over a multi-year horizon. Analyzing the company's long-term debt allows for an assessment of capital structure stability and liquidity risks during market volatility. The metric measures the issuer's ability to service loans without compromising operational activities. For Candel Therapeutics (CADL), this is critical when maintaining costly cold chains and adhering to strict clinic supply protocols.

Competitors of Candel Therapeutics (CADL)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt CG Oncology Therapeutics (CGON)|Company Long-Term Debt UroGen Pharma Ltd.|BCAX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DCTH (Delcath)|YMAB - Company Long-Term Liabilities|AURA: Company Long-Term Liabilities|ARAY - Company Long-Term Debts|sellaslifesciences.com (SLS) - Company Long-Term Debt|Actuate Therapeutics Inc. - Company Long-Term Loans and Borrowings|CTOR (Citius Oncology, Inc) - Company Long-Term Debts|Long-Term Debt TuHURA HURA|Company Long-Term Debts TARA|Company Long-Term Liabilities fatetherapeutics.com FATE|Company Long-Term Debts WHWK (Aadi Bioscience)|Company Long-Term Debts TScan Therapeutics Inc TCRX|CSBR - Company Long-Term Debt|XBIT (XBiotech Inc.) - Company Long-Term Indebtedness|CVM: Company Long-Term Debts|Company Long-Term Indebtedness OSTX|RADX (Radiopharm Theranostics Limited) - Company Long-Term Debts|Long-Term Debt Artiva ARTV|Company Long-Term Debt Adlai Nortye Ltd. (ANL)|Company Long-Term Debt VERU (Veru Corporation)|Tempest Therapeutics - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings XLO|RENB: Company Long-Term Liabilities|Mural Oncology plc - Amount of Long-Term Liabilities|KAPA: Company Long-Term Debts|OnKure Therapeutics - Company Long-Term Loans and Borrowings|GDTC (CytoMed Therapeutics Ltd) - Company Long-Term Debts|Long-Term Debt Curis Corp CRIS|Company Long-Term Debt Apollomics, Inc. (APLM)|THAR (Tharimmune Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts ADVB (Advanced Biomed)|Company Long-Term Debts Genprex Inc GNPX|CLDI - Company Long-Term Debt|Long-Term Liabilities SBFM|XBIO: Company Long-Term Debts|Long-Term Debt Salarius Pharmaceuticals Inc (SLRX)|Company Long-Term Liabilities PPBT|Company Long-Term Debts AON|Company Long-Term Liabilities BGNE (BeiGene, Ltd.)|Amount of Long-Term Liabilities CKPT|Company Long-Term Debts ELEV (Elevation Oncology, Inc.)|Long-Term Debt Volume iCAD Inc. (ICAD)|Ikena - Company Long-Term Debts|Notable Labs Corp (NTBL) - Company Long-Term Liabilities|viracta.com (VIRX) - Company Long-Term Debt|MOR - Long-Term Debt Volume|NAYA (NAYA Biosciences Inc.) - Company Long-Term Debts|Company Long-Term Liabilities Ascentage Pharma Group International (AAPGV)